Unified Patent Court (UPC) analytics are now available. Check here

Get Patent Opposition Report for Celator Pharmaceuticals

Comprehensive Analysis, Strategic Insights & Expert Evaluation – Stay Ahead in Your Patent Challenge.

Download Your Report Now

Explore Celator Pharmaceuticals's recently opposed patents, revealing key competitive challenges and strategic patent disputes in the industry. Track oppositions filed by competitors to understand technology battlegrounds and assess potential risks.

Patent NumberGrant DateTitleTotal Oppositions
EP3300601Jan 12, 2022Fixed Drug Ratios For Treatment Of Hematopoietic Cancers And Proliferative Disorders3
EP2768484Jul 24, 2019Lyophilized Liposomes2
EP2120568Nov 15, 2017Fixed Drug Ratios For Treatment Of Hematopoietic Cancers And Proliferative Disorders2